Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 60 citing Dentin: Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance.... (0.09 sec) 

Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin …


C Postic, J Girard - The Journal of clinical investigation, 2008 - pubmedcentral.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is gaining increasing recognition as a component of
the epidemic of obesity in the United States as well as in other parts of the world. NAFLD is the
most common cause of liver dysfunction and affects close to 20 million patients in the US ...
Cited by 50 - Related articles - BL Direct - All 6 versions

Benefits of lifestyle modification in NAFLD


SA Harrison, CP Day - British Medical Journal, 2007 - gut.bmj.com
Compared with our ancestors, Western societies today lead a lifestyle that is much more
sedentary, probably as a result of cultural changes stemming from modern socio-economic
morays. Taking into account differences in body size, our energy expenditure per ...
Cited by 40 - Related articles - BL Direct - All 3 versions

ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in …


… Denechaud, P Bossard, JMA Lobaccaro, L … - The Journal of …, 2008 - pubmedcentral.nih.gov
The transcription factor carbohydrate-responsive element–binding protein (ChREBP) has emerged
as a central regulator of lipid synthesis in liver because it is required for glucose-induced expression
of the glycolytic enzyme liver–pyruvate kinase (L-PK) and acts in synergy with SREBP to ...
Cited by 32 - Related articles - BL Direct - All 6 versions

Effects of CB1 antagonist on the control of metabolic functions in obese type 2 …


M Lafontan, PV Piazza, J Girard - Diabetes and Metabolism, 2007 - Elsevier
Clinical reports (RIO trials) have shown that chronic administration of a CB-cannabinoid receptor
antagonist (rimonabant) provides improvements of disturbed metabolic parameters observed
in overweight and obese patients with type 2 diabetes. The production of ...
Cited by 24 - Related articles - BL Direct - All 4 versions

The GCN2 eIF2α Kinase Regulates Fatty-Acid Homeostasis in the Liver during …

- cell.com
F Guo, DR Cavener - Cell Metabolism, 2007 - Elsevier
Metabolic adaptation is required to cope with episodes of protein deprivation and
malnutrition. GCN2 eIF2α kinase, a sensor of amino acid deficiency, plays a key role in yeast
and mammals in modulating amino acid metabolism as part of adaptation to nutrient ...
Cited by 22 - Related articles - All 9 versions

Increased hepatic CD36 expression contributes to dyslipidemia associated with …


DPY Koonen, RL Jacobs, M Febbraio, ME Young, CLM … - Diabetes, 2007 - Am Diabetes Assoc
OBJECTIVE—The etiology of type 2 diabetes often involves diet-induced obesity (DIO), which
is associated with elevated plasma fatty acids and lipoprotein associated triglycerides. Since
aberrant hepatic fatty acid uptake may contribute to this, we investigated whether ...
Cited by 16 - Related articles - BL Direct - All 4 versions

Causes and metabolic consequences of fatty liver


N Stefan, K Kantartzis, HU Haring - Endocrine Reviews, 2008 - Endocrine Soc
Type 2 diabetes and cardiovascular disease represent a serious threat to the health of the population
worldwide. Although overall adiposity and particularly visceral adiposity are established risk
factors for these diseases, in the recent years fatty liver emerged as an additional and ...
Cited by 15 - Related articles - All 4 versions

Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis

- aspetjournals.org
N Anderson, J Borlak - Pharmacological reviews, 2008 - ASPET
Cited by 14 - Related articles - All 4 versions

Glucose activates ChREBP by increasing its rate of nuclear entry and relieving …


MN Davies, BL O'Callaghan, HC Towle - Journal of Biological Chemistry, 2008 - ASBMB
Carbohydrate response element-binding protein (ChREBP) is a glucose-responsive transcription
factor that activates genes involved in de novo lipogenesis in mammals. The current model for
glucose activation of ChREBP proposes that increased glucose metabolism triggers a ...
Cited by 11 - Related articles - All 5 versions

Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic …


C Ji - Journal of gastroenterology and hepatology, 2008 - pubmedcentral.nih.gov
J Gastroenterol Hepatol. Author manuscript; available in PMC 2008 July 30. ... J Gastroenterol
Hepatol. 2008 March; 23(Suppl 1): S16–S24. ... Cheng Ji, USC-UCLA Research Center for Alcoholic
Liver and Pancreatic Diseases, USC Research Center for Liver Disease, Department of ...
Cited by 12 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google